Current opioid access, use, and problems in Australasian jurisdictions

N Gisev, G Campbell, S Lalic, S Larney… - Current Addiction …, 2018 - Springer
Abstract Purpose of Review To summarize current patterns of pharmaceutical opioid use,
extra-medical use, and harms across Australasia, with a focus on Australia and New …

The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study

C Bharat, S Larney, S Barbieri, T Dobbins… - …, 2021 - Wiley Online Library
Abstract Background and Aims There is limited evidence on the relationship between
retention in opioid agonist treatment for opioid dependence and characteristics of treatment …

Increasing the benefits and reducing the harms of prescription opioid analgesics

R Hallinan, M Osborn, M Cohen… - Drug and Alcohol …, 2011 - Wiley Online Library
Issues. Consumption of prescription opioid analgesics (POAs) in Australia has increased
steadily in recent years, raising concerns of increasing harms including overdose and …

Economic analysis of out-of-pocket costs among people in opioid agonist treatment: a cross-sectional survey in three Australian jurisdictions

AD Tran, R Chen, S Nielsen, E Zahra… - International Journal of …, 2022 - Elsevier
Background Out-of-pocket costs for opioid agonist treatment (OAT) constitute a barrier to
treatment entry and retention. This study examines OAT clients' total out-of-pocket costs …

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study

S Larney, M Hickman, DA Fiellin, T Dobbins… - BMJ open, 2018 - bmjopen.bmj.com
Introduction North America is amid an opioid use epidemic. Opioid agonist treatment (OAT)
effectively reduces extramedical opioid use and related harms. As with all pharmacological …

Factors influencing pharmacy services in opioid substitution treatment

BB Chaar, H Wang, CA Day, JR Hanrahan… - Drug and alcohol …, 2013 - Wiley Online Library
Abstract Introduction and Aim Heroin dependence is a serious health burden in A ustralia.
Opioid substitution treatment (OST) has been delivered in A ustralian community …

[HTML][HTML] Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

AJ Dunlop, AL Brown, C Oldmeadow, A Harris… - Drug and Alcohol …, 2017 - Elsevier
Background Access to opioid agonist treatment can be associated with extensive waiting
periods with significant health and financial burdens. This study aimed to determine whether …

A cost‐effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence

N Gisev, M Shanahan, DJ Weatherburn, RP Mattick… - …, 2015 - Wiley Online Library
Aim Although opioid substitution therapy (OST) immediately after prison release reduces
mortality, the cost‐effectiveness of treatment has not been examined. Therefore, we …

Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study …

HHK Wilson, BH Roxas, N Lintzeris, MF Harris - BMC Primary Care, 2024 - Springer
Background Chronic pain is a debilitating and common health issue. General Practitioners
(GPs) often prescribe opioids to treat chronic pain, despite limited evidence of benefit and …

Pharmaceutical opioid analgesic and heroin dependence: how do treatment‐seeking clients differ in Australia?

S Nielsen, R Bruno, N Lintzeris, J Fischer… - Drug and Alcohol …, 2011 - Wiley Online Library
Abstract Introduction and Aims. Non‐prescribed use of pharmaceutical opioid analgesics
(POA) has been escalating internationally. In Australia, few studies have examined if POA …